[Form 4] Sharps Technology Inc. Insider Trading Activity

Rhea-AI Filing Summary

Reporting person Zhang Yuwen, Chief Investment Officer and director of Sharps Technology Inc. (STSS), reported a grant of stock options on 08/23/2025. The award consists of 500,000 stock options with an exercise price of $6.41 per share and a ten‑year term expiring on 08/22/2035. The options vest in four equal installments of 125,000 shares each, with 25% vesting every three months beginning on 08/23/2025. Following the grant, the reporting person beneficially owns 500,000 underlying common shares attributable to the options, held directly.

Positive

• Large incentive grant of 500,000 options aligns executive interests with shareholder value creation
• Clear vesting schedule: four equal tranches (125,000) with 25% vesting every three months starting 08/23/2025
• Long option term through 08/22/2035 preserves extended upside

Negative

• Potential near-term dilution if all 500,000 options are exercised
• Rapid vesting (quarterly over three months) concentrates incentive in the short term and may reduce long-term retention effects
• Cash requirements on exercise at $6.41 per share could be material to the holder

Insights

Executive Compensation Analyst

Grant aligns pay with future share performance while concentrating immediate equity upside.

The 500,000-option award at a $6.41 exercise price vests rapidly over four quarterly tranches starting 08/23/2025, tying significant potential equity retention to short-term milestones and continued service. Rapid quarterly vesting front-loads near-term incentive while keeping a long expiration (08/22/2035), which preserves long-dated upside for the officer.

The arrangement increases immediate potential dilution if exercised; monitor dilution relative to outstanding shares and the company's equity plan capacity over the next 12 months. Watch for any related SEC disclosures or subsequent exercises that will crystallize dilution and cash proceeds from exercises.

Corporate Governance Specialist

Vesting schedule and insider status are material for governance and insider-trading windows.

The reporting person is both a director and an officer, which makes option grants subject to heightened governance scrutiny and standard insider trading restrictions. The filing shows the grant meets formal disclosure requirements and indicates direct ownership form.

Compliance observers should note the first vesting date 08/23/2025 and consider blackout periods or trading plans around those dates; any future exercises or sales will require new Section 16 filings and may affect market perception in the near term.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zhang Yuwen

(Last) (First) (Middle)

C/O SHARPS TECHNOLOGY, INC.

105 MAXESS ROAD, STE. #124

(Street)

MELVILLE NY 11747

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$6.41	08/23/2025		A		500,000		08/23/2025	08/22/2035	Common Stock	500,000(1)	$0	500,000	D

Explanation of Responses:

1. On August 23, 2025 the reporting person was granted options under the 2025 Equity Incentive Plan to purchase an aggregate of 500,000 shares of common stock of the Issuer, with the options vesting and becoming exercisable in four equal installments of 125,000 shares each, with 25% vesting every three months, beginning August 23, 2025, and expires on August 22, 2035.

	/s/ Zhang Yuwen	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did STSS insider Zhang Yuwen receive on 08/23/2025?

The reporting person was granted 500,000 stock options to purchase common stock with an exercise price of $6.41 per share, issued on 08/23/2025.

When do the options vest and when do they expire for STSS?

Options vest in four equal installments of 125,000 shares each with 25% vesting every three months beginning 08/23/2025, and they expire on 08/22/2035.

How many shares does Zhang Yuwen beneficially own after the grant?

Following the reported transaction the reporting person beneficially owns rights to 500,000 underlying common shares attributable to the options.

What is the exercise price and cash needed to exercise all options?

The exercise price is $6.41 per share; exercising all 500,000 options would require $3,205,000 in aggregate cash (500,000 × $6.41).

What roles does Zhang Yuwen hold at Sharps Technology (STSS)?

The reporting person is identified as both a director and the company's Chief Investment Officer.